Clinical Trial Update: Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether reversal of hyperuricemia affects features of metabolic syndrome in gout patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Metabolic Syndrome

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Gout | Phase 4 | Status: COMPLETED | Results posted: 2017-01-13